Mark W Orme

This inventor holds 68 USPTO granted patents and 5 published patent applications, plus 2 CIPO patents and 3 EPO patents, primarily in Ophthalmic Disease Treatment (CPC class C07C). Top assignees: Acucela Inc., Lilly Icos LLC, Zymogenetics, Inc.. Active years: 1995-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mark W Orme. Retrieved from https://idiyas.com/inventor/mark-w-orme

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 68 (Patent Applications = 5)

% Patents Active = 44.1

CIPO Patents = 2 (Patent Applications = 2)

EPO Patents = 3 (Patent Applications = 4)

Average Co-Inventor Count = 5.1

ph-index = 15

Forward Citations = 1,271(Granted Patents)

Forward Citations (Not Self Cited) = 1,180(Dec 10, 2025)

Inventors with similar research interests:

Company Filing History:

The University of Texas System

patents

7. 2 out of 834,570

Other

patents

where one patent can have more than one assignee

Years Active: 1995-2024

Loading Chart...

Areas of Expertise:

VAP-1 Inhibitors

Alkoxy Compounds

Ophthalmic Diseases

Amine Derivatives

Styrenyl Derivatives

Alkynyl Phenyl Derivatives

Substituted Heterocyclic Compounds

PDE5-Inhibitors

Carboline Derivatives

Fused Heterocyclic Derivatives

Modified Pictet-Spengler Reaction

Chemical Compounds

68 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12162871 - Inhibitors of VAP-1 (2024-12-10),

2. 12037334 - Inhibitors of VAP-1 (2024-07-16),

3. 12029708 - Alkoxy compounds for disease treatment (2024-07-09),

4. 11787791 - Inhibitors of VAP-1 (2023-10-17),

5. 11446261 - Alkoxy compounds for disease treatment (2022-09-20),

6. 10639286 - Alkoxy compounds for disease treatment (2020-05-05),

7. 10201545 - Styrenyl derivative compounds for treating ophthalmic diseases and disorders (2019-02-12),

8. 10188615 - Alkoxy compounds for disease treatment (2019-01-29),

9. 9737496 - Alkoxy compounds for disease treatment (2017-08-22),

10. 9464033 - Alkynyl phenyl derivative compounds for treating ophthalmic diseases and disorders (2016-10-11),

11. 9458088 - Alkoxy compounds for disease treatment (2016-10-04),

12. 9452153 - Amine derivative compounds for treating ophthalmic diseases and disorders (2016-09-27),

13. 9447078 - Substituted heterocyclic compounds for disease treatment (2016-09-20),

14. 9421210 - Styrenyl derivative compounds for treating ophthalmic diseases and disorders (2016-08-23),

15. 9314467 - Styrenyl derivative compounds for treating ophthalmic diseases and disorders (2016-04-19),

Title: Unveiling the Inventive World of Mark W Orme

Introduction:

Mark W Orme is a prolific inventor hailing from Seattle, WA (US) with an impressive track record of 67 patents to his name. His innovative spirit and dedication to pushing boundaries in the field of science and technology have led to groundbreaking developments that have the potential to shape the future.

Latest Patents:

Among his latest patents is the creation of "Inhibitors of VAP-1," which introduces compounds and methods for modulating VAP-1 activity. Additionally, his work on "Alkoxy Compounds for Disease Treatment" showcases his contributions to treating neurodegenerative diseases, particularly ophthalmic conditions like age-related macular degeneration (AMD) and Stargardt's Disease.

Career Highlights:

Mark W Orme has made significant contributions to the innovations landscape through his tenure at companies like Acucela Inc. and Lilly Icos LLC. His expertise and ingenuity have been instrumental in driving forward advancements in the pharmaceutical and biotechnology sectors.

Collaborations:

Throughout his career, Mark W Orme has collaborated with esteemed professionals such as Vladimir Aleksandrovich Kuksa and Ian L Scott. These partnerships have not only enhanced the quality of his work but have also fostered a culture of innovation and excellence.

Conclusion:

In conclusion, Mark W Orme stands as a beacon of innovation, with his inventive prowess and relentless pursuit of scientific excellence shaping the realm of patents and inventions. His contributions have not only enriched the field of ophthalmic research but have also paved the way for future breakthroughs in the realm of neurodegenerative disease treatment. We eagerly anticipate the next chapter of innovation from this visionary inventor.

Profile summary based on public USPTO records.